Article

Femtosecond laser non-invasive RIS next for presbyopia

The latest innovation in the quest for presbyopic correction may be high-repetition rate femtosecond laser non-invasive refractive index shaping. Scott MacRae, MD, reviewed the experimental results of this procedure during the Innovators' Session.

Chicago-The latest innovation in the quest for presbyopic correction may be high-repetition rate femtosecond laser non-invasive refractive index shaping (RIS). Scott MacRae, MD, reviewed the experimental results of this procedure during the Innovator’s Session.

Compared with LASIK, RIS leaves the corneal shape the same and requires about 100 times less energy than that required to create a laser flap, said Dr. MacRae, director of refractive services, Department of Ophthalmology, University of Rochester, Rochester, NY.

“The goal is to make this a minimally invasive surgery,” he said.

Femtosecond laser RIS, which works by localized accumulation of heat, does not cause endothelial, epithelial, or stromal disruption or dry eye; no special postoperative care is needed; there are no complications associated with LASIK flaps or the PRK soft contact lens falling out; and there is no need for antibiotics. This also results in less patient anxiety and greater patient acceptance of the technology.

The procedure has been tested in hydrogels, with a follow-up of about 2.5 years, and no material damage has been evident; the effect is invisible to the naked eye and the refraction pattern shows no evidence of scatter. In cats, no corneal damage was evident and there has been no regression; however, the animals have been followed for only 7 weeks.

Thus far, Dr. MacRae said that the procedure is capable of producing a refractive change of almost 3 D.

“This is an ultrafast, non-invasive procedure that changes the refractive index,” Dr. MacRae said. “The changes occur below the threshold of tissue damage. Using this technique, we expect to achieve custom vision correction of ± 3 D of sphere or astigmatism on corneas, lenses, and hydrogels. This field is moving fast and it is very exciting.”

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.